Artificial Intelligence in CT for Predicting Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients: A Meta-analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
1778 patients in internal validation sets and 4072 patients in external validation sets were included.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
AI could potentially serve as a valuable diagnostic support tool, though further prospective validation is warranted. Limitations include high heterogeneity among studies and insufficient external validation in diverse populations.
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.9%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[PURPOSE] This meta-analysis aims to evaluate the diagnostic performance of CT-based artificial intelligence (AI) in diagnosing cervical lymph node metastasis (LNM) of papillary thyroid cancer (PTC).
- p-value P<0.05
- 95% CI 0.71-0.86
- 연구 설계 meta-analysis
APA
Zeng S, Liu Y, et al. (2025). Artificial Intelligence in CT for Predicting Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients: A Meta-analysis.. Academic radiology, 32(5), 2554-2568. https://doi.org/10.1016/j.acra.2025.02.007
MLA
Zeng S, et al.. "Artificial Intelligence in CT for Predicting Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients: A Meta-analysis.." Academic radiology, vol. 32, no. 5, 2025, pp. 2554-2568.
PMID
40000328 ↗
Abstract 한글 요약
[PURPOSE] This meta-analysis aims to evaluate the diagnostic performance of CT-based artificial intelligence (AI) in diagnosing cervical lymph node metastasis (LNM) of papillary thyroid cancer (PTC).
[METHODS] A systematic search was conducted in PubMed, Embase, and Web of Science databases through December 2024, following PRISMA-DTA guidelines. Studies evaluating CT-based AI models for diagnosing cervical LNM in patients with pathologically confirmed PTC were included. The methodological quality was assessed using a modified QUADAS-2 tool. A bivariate random-effects model was used to calculate pooled sensitivity, specificity, and area under the curve (AUC). Heterogeneity was evaluated using I statistics, and meta-regression analyses were performed to explore potential sources of heterogeneity.
[RESULTS] 17 studies comprising 1778 patients in internal validation sets and 4072 patients in external validation sets were included. In internal validation sets, AI demonstrated a sensitivity of 0.80 (95% CI: 0.71-0.86), specificity of 0.79 (95% CI: 0.73-0.84), and AUC of 0.86 (95% CI: 0.83-0.89). Radiologists suggested comparable performance with sensitivity of 0.77 (95% CI: 0.64-0.87), specificity of 0.79 (95% CI: 0.72-0.85), and AUC of 0.85 (95% CI: 0.81-0.88). Subgroup analyses revealed that deep learning methods outperformed machine learning in sensitivity (0.86 vs 0.72, P<0.05). No significant publication bias was found in internal validation sets for AI diagnosis (P=0.78).
[CONCLUSION] CT-based AI showed comparable diagnostic performance to radiologists for detecting cervical LNM in PTC patients, with deep learning models showing superior sensitivity. AI could potentially serve as a valuable diagnostic support tool, though further prospective validation is warranted. Limitations include high heterogeneity among studies and insufficient external validation in diverse populations.
[METHODS] A systematic search was conducted in PubMed, Embase, and Web of Science databases through December 2024, following PRISMA-DTA guidelines. Studies evaluating CT-based AI models for diagnosing cervical LNM in patients with pathologically confirmed PTC were included. The methodological quality was assessed using a modified QUADAS-2 tool. A bivariate random-effects model was used to calculate pooled sensitivity, specificity, and area under the curve (AUC). Heterogeneity was evaluated using I statistics, and meta-regression analyses were performed to explore potential sources of heterogeneity.
[RESULTS] 17 studies comprising 1778 patients in internal validation sets and 4072 patients in external validation sets were included. In internal validation sets, AI demonstrated a sensitivity of 0.80 (95% CI: 0.71-0.86), specificity of 0.79 (95% CI: 0.73-0.84), and AUC of 0.86 (95% CI: 0.83-0.89). Radiologists suggested comparable performance with sensitivity of 0.77 (95% CI: 0.64-0.87), specificity of 0.79 (95% CI: 0.72-0.85), and AUC of 0.85 (95% CI: 0.81-0.88). Subgroup analyses revealed that deep learning methods outperformed machine learning in sensitivity (0.86 vs 0.72, P<0.05). No significant publication bias was found in internal validation sets for AI diagnosis (P=0.78).
[CONCLUSION] CT-based AI showed comparable diagnostic performance to radiologists for detecting cervical LNM in PTC patients, with deep learning models showing superior sensitivity. AI could potentially serve as a valuable diagnostic support tool, though further prospective validation is warranted. Limitations include high heterogeneity among studies and insufficient external validation in diverse populations.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Multiscale imaging on proton pump-driven acidity for assessing tumor progression and metastasis.
- Tumor microenvironment-driven ST6Gal-Ⅰ activation promotes aggressiveness in gastric signet-ring cell carcinoma via ITGβ1/FAK/Paxillin signaling.
- A real-world study of Trifluridine/Tipiracil (TAS-102) combined with bevacizumab as the late-line treatment of metastatic colorectal cancer.
- Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3-Mediated Cytoskeletal Remodeling.
- The metabolic crossroads: glycolysis in cancer and neurodegeneration.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.